tirzepatide vs semaglutide side effects comparison study results ✨ vs. — what's the difference? ✨ Both are powerful tools for weight Frontiers | Tirzepatide vs. semaglutide

At 1st Optimal, our medical team uses comprehensive data from lab testslike DUTCH hormone panels and metabolic markersto determine the precise dosage and timing that will work best for you

Here's the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations

Theres also a more serious consideration: blood sugar

Had people been warned about the severity of these rare complications, they might not have taken Zepbound in the first place

In other words, because GLP-1 medication contains such high doses of the hormone, it may also have an effect in the joints, where levels are otherwise low